HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,739,072 | +10.3% | 2,936,633 | -1.9% | 0.77% | +15.1% |
| Q2 2023 | $307,995,227 | +10.3% | 2,994,606 | +17.0% | 0.67% | +6.9% |
| Q1 2023 | $279,279,656 | +59.0% | 2,558,912 | +65.8% | 0.63% | +49.0% |
| Q4 2022 | $175,673,060 | +182.1% | 1,543,700 | +53.4% | 0.42% | +172.7% |
| Q3 2022 | $62,276,000 | +564.5% | 1,006,243 | +756.4% | 0.15% | +633.3% |
| Q2 2022 | $9,372,000 | -76.6% | 117,500 | -69.1% | 0.02% | -72.4% |
| Q1 2022 | $39,980,000 | +147.3% | 380,000 | +153.3% | 0.08% | +162.1% |
| Q4 2021 | $16,164,000 | -92.3% | 150,000 | -92.1% | 0.03% | -92.9% |
| Q3 2021 | $208,674,000 | -1.0% | 1,905,000 | -15.3% | 0.41% | -0.5% |
| Q2 2021 | $210,690,000 | +43.1% | 2,250,000 | +40.6% | 0.41% | +37.2% |
| Q1 2021 | $147,264,000 | -17.8% | 1,600,000 | -34.7% | 0.30% | -23.0% |
| Q4 2020 | $179,218,000 | -37.5% | 2,450,000 | -33.6% | 0.39% | -45.5% |
| Q3 2020 | $286,699,000 | +58.4% | 3,690,772 | +13.4% | 0.72% | +55.1% |
| Q2 2020 | $180,966,000 | +399.9% | 3,255,949 | +225.6% | 0.46% | +420.2% |
| Q4 2019 | $36,200,000 | -11.4% | 1,000,000 | -33.3% | 0.09% | -11.0% |
| Q3 2019 | $40,845,000 | +21.3% | 1,500,000 | +7.1% | 0.10% | +19.0% |
| Q2 2019 | $33,684,000 | – | 1,400,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |